Monitoring Program Flags Cancer Patients at Risk of Highly Toxic Chemotherapy Side Effects

November 10, 2023


Read time:

5-15 mins
Iv Fluid Drip Medication Therapy
Presented by Health Lab

Researchers from the University of Michigan are using a genetics program to alert cancer patients about the potential of a variant that puts someone at high risk of effects from chemotherapy. Daniel L. Hertz, Pharm.D., Ph.D., associate professor of pharmacy, discusses clinical treatment decisions and how evidence is showing how this testing can be effective.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.